Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Neurosurgery. 2011 Feb;68(2):280-89; discussion 290. doi: 10.1227/NEU.0b013e3181ff9cbb.
Surgery remains the first and most important treatment modality for the majority of solid tumors. Across a range of brain tumor types and grades, postoperative residual tumor has a great impact on prognosis. The principal challenge and objective of neurosurgical intervention is therefore to maximize tumor resection while minimizing the potential for neurological deficit by preserving critical tissue.
To introduce the integration of desorption electrospray ionization mass spectrometry into surgery for in vivo molecular tissue characterization and intraoperative definition of tumor boundaries without systemic injection of contrast agents.
Using a frameless stereotactic sampling approach and by integrating a 3-dimensional navigation system with an ultrasonic surgical probe, we obtained image-registered surgical specimens. The samples were analyzed with ambient desorption/ionization mass spectrometry and validated against standard histopathology. This new approach will enable neurosurgeons to detect tumor infiltration of the normal brain intraoperatively with mass spectrometry and to obtain spatially resolved molecular tissue characterization without any exogenous agent and with high sensitivity and specificity.
Proof of concept is presented in using mass spectrometry intraoperatively for real-time measurement of molecular structure and using that tissue characterization method to detect tumor boundaries. Multiple sampling sites within the tumor mass were defined for a patient with a recurrent left frontal oligodendroglioma, World Health Organization grade II with chromosome 1p/19q codeletion, and mass spectrometry data indicated a correlation between lipid constitution and tumor cell prevalence.
The mass spectrometry measurements reflect a complex molecular structure and are integrated with frameless stereotaxy and imaging, providing 3-dimensional molecular imaging without systemic injection of any agents, which can be implemented for surgical margins delineation of any organ and with a rapidity that allows real-time analysis.
手术仍然是大多数实体瘤的首选和最重要的治疗方式。在各种脑肿瘤类型和分级中,术后残留肿瘤对预后有很大影响。因此,神经外科干预的主要挑战和目标是在保留关键组织的同时最大限度地切除肿瘤,从而最大限度地减少潜在的神经功能缺损。
介绍解吸电喷雾电离质谱技术在手术中的应用,以实现对活体分子组织特征的体内分析,并在不进行全身注射造影剂的情况下实现肿瘤边界的术中定义。
我们使用无框架立体定向取样方法,并将三维导航系统与超声手术探头集成,获得图像配准的手术标本。使用环境解吸/电离质谱对样本进行分析,并与标准组织病理学进行验证。这种新方法将使神经外科医生能够在手术过程中使用质谱技术实时检测肿瘤对正常大脑的浸润,并获得无外源性试剂的、具有高灵敏度和特异性的空间分辨分子组织特征。
通过使用质谱术实时测量分子结构,并使用该组织特征方法来检测肿瘤边界,为概念验证提供了证据。对一名复发性左额叶少突胶质细胞瘤患者进行了多次取样,该患者的肿瘤为世界卫生组织二级,存在 1p/19q 染色体缺失,质谱数据表明脂质组成与肿瘤细胞的普遍性之间存在相关性。
质谱测量反映了复杂的分子结构,并与无框架立体定向和成像技术相结合,提供了无需全身注射任何试剂的三维分子成像,可以用于任何器官的手术边界描绘,并具有允许实时分析的快速性。